BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • BCI
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, August 3, 2026
Home » Topics » Briefs » Appointments and advancements

Appointments and advancements
Appointments and advancements RSS Feed RSS

Appointments and advancements for April 22, 2025

April 22, 2025
New hires and promotions in the med-tech industry, including: Fujifil, Harbinger Health, Nanodrops.
Read More

Appointments and advancements for April 22, 2025

April 22, 2025
New hires and promotions in the biopharma industry, including: Apellis, Immunovant, Monument, Neurotech, Newamsterdam, Zymeworks.
Read More

Appointments and advancements for April 22, 2025

April 22, 2025
New hires and promotions in biopharma in Asia-Pacific, including: Chemomab, Hebe Biotechnology.
Read More

Appointments and advancements for April 21, 2025

April 21, 2025
New hires and promotions in the med-tech industry, including: Dario Health, Healthcare Integrated Technologies, Inspire Medical, Neurotech.
Read More

Appointments and advancements for April 21, 2025

April 21, 2025
New hires and promotions in the biopharma industry, including: Adicet, Bright Peak, Design, Mindimmune, Neuvogen.
Read More

Appointments and advancements for April 17, 2025

April 17, 2025
New hires and promotions in the med-tech industry, including: Cytosorbents, Terumo Blood and Cell Technologies.
Read More

Appointments and advancements for April 17, 2025

April 17, 2025
New hires and promotions in the biopharma industry, including: Addgene, Airna, Arrowhead, Concept, Conduit, Decoy, Madrigal, Neuronos, Organon, Phathom, Protara.
Read More

Appointments and advancements for April 16, 2025

April 16, 2025
New hires and promotions in the med-tech industry, including: Aurora Spine, Ezra AI, Synapse Health.
Read More

Appointments and advancements for April 16, 2025

April 16, 2025
New hires and promotions in the biopharma industry, including: Chemomab, Dyne, GC Therapeutics, Rapt, Remix, Tharimmune.
Read More

Appointments and advancements for April 15, 2025

April 15, 2025
New hires and promotions in the med-tech industry, including: Instylla, Parexel, Turing Medical.
Read More
Previous 1 2 … 50 51 52 53 54 55 56 57 58 … 329 330 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Aug. 3, 2026.
  • Tuojie Biotech (Shanghai) synthesizes new SARM1 inhibitors

    BioWorld Science
    Tuojie Biotech (Shanghai) Co. Ltd. has prepared and tested NAD(+) hydrolase SARM1 (SAMD2; MyD88-5) inhibitors found to be potentially useful for the treatment of...
  • Silhouette illustration of DNA gene editing

    Death in Chinese gene-editing trial exposes ethical fault lines

    BioWorld
    The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...
  • Mitochondria

    Seed funding at Adjuvia to treat mitochondrial dysfunction

    BioWorld Science
    Adjuvia Therapeutics Inc. has closed a $8 million series seed financing round to advance its work developing therapeutics to treat mitochondrial dysfunction and...
  • Skin through magnifier

    Replimune’s RP-1 for melanoma wins over FDA adcom

    BioWorld
    Following two complete response letters in the past year, Replimune Group Inc.’s RP-1 (suvolimogene oderparepvec) for unresectable metastatic cutaneous melanoma...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
    • Videos
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing